VectorY
Michael Wyzga has extensive work experience in the financial and investment sectors. Michael'smost recent role was as the Chief Financial Officer at VectorY starting in 2023. Prior to that, they served as the Chief Financial Officer at Yumanity Therapeutics from 2021 to 2022. Michael also worked at Needham & Company as the Vice President in Healthcare Investment Banking from 2014 to 2021, and at Citi as an Analyst in Healthcare Corporate & Investment Banking from 2011 to 2013.
Michael Wyzga has a Master of Business Administration (MBA) degree from Cornell Johnson Graduate School of Management. Prior to their MBA, they obtained a Bachelor of Science (B.S.) degree in Finance from Lehigh University. Michael also holds additional certifications, including Series 63, Series 7, and Series 79, although information about the institutions and dates of obtaining these certifications is not provided.
This person is not in any offices
VectorY
VectorY combines the therapeutic potential of antibodies and gene therapy to develop long-lasting therapeutic solutions for large disease areas of high unmet medical need. By combining state-of-the-art technologies and novel and scientific concepts, VectorY’s mission is to bring innovative therapies to patients worldwide.